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Abstract
Background: Accreditation of hospitals and other institutions is a widely used instrument for the quality assurance
in health care. However, relevant literature regarding the economic evaluation of hospital accreditation is still missing.
To date no formal Cost-Benefit Analysis (CBA) or Cost-Utility Analysis (CUA) has been carried out.
Methods: This study uses an existing framework specifically developed for the economic evaluation of hospital
accreditation. Based on this framework, we identify and quantify the costs and selected benefits of the re-accreditation
of a Swiss acute care hospital. Costs are identified and quantified by conducting key informant and expert interviews.
Benefits are identified by hospital experts and rated using a newly developed validation tool.
Results: Costs of the re-accreditation amount to about CHF 870'000 (internal and external costs). Benefits in
quality management (QM) and in the critical incident reporting system (CIRS) are quantified and rated by the
hospital experts in the following order: (1) development or promotion of a quality or safety culture, (2) implementation
of a hospital-wide complaint management, (3) fulfillment of the hospital vision, (4) improved image upon stakeholders
(patients, suppliers etc.), (5) improved image in policy, (6) quality dashboard, (7) preparation of centralized quality
documents, and (8) avoidance of liability cases.
Conclusion: This study provides detailed information about costs and selected benefits associated with the
re-accreditation of a Swiss acute care hospital. As opposed to the costs, benefits could not be monetized but
were quantified using an expert rating to illustrate the impacts of the re-accreditation. Overall, our study confirms the
difficulties in the economic evaluation of hospital accreditation, but it makes a step towards a formal CUA.
Keywords: Hospital accreditation, Economic evaluation, Costs, Benefits, Validation tool
Background
The number of accreditation programs and accredited
hospitals has increased considerably over the last de-
cades. In 2000, the World Health Organization identified
as many as 36 nationwide accreditation programs and
the number of programs has doubled every five years
since 1990 [1]. In the United States, accreditation is a re-
quirement for reimbursement by public health programs
and over 85 % of the hospitals are accredited [2]. In
Switzerland, the focus of this study, there are different
accreditation programs in place, e.g., on the accredit-
ation of entire hospitals, subdivisions or centers [16].
Persistent harm during health service delivery is an
issue [3, 4]. Moreover, accountability and safety in health
care has increasingly become an international concern
[4]. In this regard, accreditation programs aim to im-
prove the quality of care [5]. On the downside, achieving
accreditation generates significant expenditures [6]. And
whether accreditation contributes to a quality improve-
ment is still controversial. Some argue that it does, in
the sense of providing a useful tool to stimulate im-
provement in health service organizations [7] and in the
processes of care and clinical outcomes [8]. In contrast,
Grepperud [2] argues that there is no convincing evi-
dence for quality improvement.
Despite its wide international implementation and
emerging importance, relevant literature seems to be
missing especially regarding the economic evaluation of
hospital accreditation. For this reason, more research in
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the area of health service accreditation seems to be well-
justified [1, 4, 7, 9, 10]. To gain a better understanding
of the impact of hospital accreditation there is a strong
need to economically evaluate such efforts. This study
attempts to deliver a basis for further in-depth analysis
in this context.
Related literature
So far, several studies have tried to assess the impact of
hospital accreditation. However, we are not aware of any
formal economic evaluation in the literature, which is
confirmed by Mumford et al. [6] who conducted a sys-
tematic review on the use of economic evaluation tech-
niques in connection with health services accreditation.
Nevertheless, there exist different attempts to analyze
the impact of hospital accreditation that are mainly
based on meta-analyses, single cost or benefit studies.
Greenfield and Braithwaite [10] systematically reviewed
66 articles that examine health sector accreditation. Their
review included the impact of accreditation on specific
topics. For some topics they found consistent, for others
inconsistent evidence and for some they were not able to
draw any conclusion. A narrative review of 122 articles
(categorized into key thematic topics) by Hinchcliff et al.
[7] confirmed the multifaceted picture. However, the study
also identified knowledge gaps concerning accreditation
research (e.g., on the relationship between accreditation
and suitable quality measures and indicators, or on the
financial impact of accreditation of health services).
Braithwaite et al. [11] analyzed the association between
accreditation results and clinical or organizational per-
formance measures. The findings were not entirely
conclusive but indicate that a better accreditation per-
formance was associated with an improvement in qual-
ity measures.
As an example of a cost study, Zarkin et al. [12] esti-
mated the costs of preparing and undergoing accredit-
ation of a methadone treatment site using survey data.
They estimated total costs of accreditation as $48'005
which equalled to about 5 % of the clinic’s annual oper-
ating costs. Sack et al. [13] studied the association be-
tween hospital accreditation and patient satisfaction with
hospital care. The authors could not find a link between
hospital accreditation status and improved patient satis-
faction (benefit). Grepperud [2] focused on the decision
to accredit a hospital and its social effectivity, which may
be seen as a different approach to evaluate accreditation
performance.
Most related to our study is Mumford et al. [4] who
intend to apply a formal Cost-Benefit Analysis (CBA) on
acute care accreditation. This is a current, ongoing study
based on a newly developed framework called SIQNS
(Scope and objectives, Identification, Quantification, Net
present value, Sensitivity analysis). This framework will
be presented in greater detail in the methods section
below. Finally, Mumford et al. [14] reviewed the suitabil-
ity of hand hygiene as a possible quality indicator of ac-
creditation outcomes. Data on hand hygiene compliance
rates and hospital accreditation scores for 96 hospitals
were analyzed, but at the end the suitability of the indi-
cator was denied.
Quality assurance in the Swiss healthcare system
In the Swiss health care system, each of the cantons is
responsible for the planning and provision of care.
Nevertheless, federal law is regulating some parts of the
health system, which also affects the regulation of qual-
ity assurance. All health care providers in Switzerland
are obliged by law to ensure the quality of care. How-
ever, each health care provider is self-responsible for its
quality assurance, and the accreditation and implemen-
tation of a Quality Management (QM) system is volun-
tary [15].
Accreditation bodies
The Joint Commission (United States) is one of the most
prominent accreditation providers in the world. How-
ever, European accreditation programs have emerged
over the years and accounted for about half of all pro-
grams worldwide in 2003 [1]. On top of all the national
and international accreditation bodies, the International
Society for Quality in Health Care (ISQua) serves as the
peak body [4]. The ISQua defines accreditation as “a
public recognition of the achievement of standards by an
organisation demonstrated through independent assess-
ment in relation to set standards”.
The term accreditation in Switzerland is often used to
state an acceptance of organizations by associations or
the state [16]. In the context of peer-review assessments,
the term “certification” is more common. Nonetheless,
we will use “accreditation” when relating to peer-review
assessments consistent with the international literature.
The focus of our study lies on the accreditation body
sanaCERT suisse (sanaCERT). SanaCERT is a Swiss
foundation (non-governmental organization) founded
in 2001. The sanaCERT accreditation program is similar
to the programs of the Joint Commission, Accreditation
Canada and the Australian Council on Healthcare Stan-
dards (ACHS). SanaCERT aims to review the achieve-
ment of its quality standards during on-site audits by
using the concept of peer reviews [17]. The objective of
the audit is to examine the conformity with the stan-
dards. Each health care institution chooses a set of
standards they intend to focus on, except for QM,
which is mandatory and cannot be dropped. To meet
the requirements of the chosen standards the institu-
tion has to provide documented information as well as
oral statements. In the case of a sufficient result, the
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institution receives an accreditation status from sana-
CERT. Re-accreditation takes place every three years
under the condition of yearly routine surveillance visits.
Cantonal Hospital of Graubünden
The cantonal hospital of Graubünden (KSGR), a 355-bed
(only acute-care) teaching hospital operates as a central-
ized hospital in the south-eastern region of Switzerland.
In total, the hospital has almost 1900 employees and the
revenue amounted to just over 300 Mio. Swiss Francs in
2013 [18]. The hospital was for the first time accredited by
sanaCERT in 2011. After three years, the re-accreditation
took place in November 2014. The KSGR has decided on
eight standards: QM (main standard), survey of patients’
opinion, surgery, Critical Incident Reporting System
(CIRS), employed people and hospital, emergency, nutri-
tion and safe medication, which were examined by sana-
CERT for the re-accreditation.
Scope and objectives
Based on the SIQNS framework by Mumford et al. [4],
the first aim of this study is to identify the costs and
benefits associated with the re-accreditation of the
KSGR. Quantification and monetization of benefits in
general is a difficult task. For this reason, the study’s sec-
ond aim is to elaborate whether it is possible to quantify
selected benefits. To this end, we develop a new valid-
ation tool that allows hospital experts to rate benefits.
Finally, as there is few literature available on the eco-
nomic evaluation of hospital accreditation, every contri-
bution concerning the topic may be useful. Hence, our
third aim is to discuss directions for further research
and more detailed analyses based on our results.
The framework by Mumford et al. [4] is used as a
basis to answer the following research question: What
are the costs and benefits of the present re-accreditation
of an acute care hospital and is it possible to compare
them in a formal cost-benefit analysis in this setting? It
is not intended to answer the question as to whether the
decision to re-accredit was an efficient one. This is a dif-
ferent topic, as we can see from Grepperud [2].
Methods
Mumford et al. [4] introduced the SIQNS framework for
the economic evaluation of accreditation. The model
and its methodological steps are summarized in Fig. 1.
The SIQNS framework was created for assessment by
different institutions [4]. This section is devoted to de-
scribing the methodological procedure according to the
SIQNS framework, focusing on the first three parts
(scope and objectives, identification, and quantification).
Step 1: Scope and objectives
Scope and objectives of our study were stated in section
2. We also provided a review of the related literature
and background information on hospital accreditation as
well as the relevance and aims of our study, as suggested
by Mumford et al. [4].
Step 2: Identification of costs and benefits
The second step of the SIQNS framework comprises
the identification and recognition of costs and benefits.
Benefits are understood as a general concept here,
representing any improvement/change of an indicator
in the hospital environment, which for example can be
the improvement of processes, documentation or safety
aspects. We approached the identification of costs and
benefits by conducting key informant interviews. The
following standards were selected for deeper review
based on expert opinion: QM, surgery, CIRS, and nutri-
tion. QM and CIRS cover hospital wide projects, which
in turn represent hospital wide costs and benefits of the
re-accreditation. The other two standards are more nar-
row and provide department specific costs and benefits
of the re-accreditation. Once the respective standards
were selected, each project leader from the four identi-
fied standards was contacted and interviewed using a
semi-structured interview guideline (Additional file 1).
The aim of the interviews was to identify standard spe-
cific costs and benefits.
To identify the costs, interviewees were asked to re-
port the expenses and other costs that were docu-
mented. If costs were not documented, experts were
asked to estimate them. Additionally, the hospital quality
manager estimated the costs of the standards not
Fig. 1 SIQNS Framework by Mumford et al. [4]
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selected for deeper review: survey of patients’ opinion,
employed people and hospital, emergency, and safe
medication according to Mumford et al. [4] to cover the
costs of the entire project. If it was not possible for the
quality manager to estimate the costs, the project leaders
from the respective standards were contacted to collect
the missing information.
To identify the benefits, interviewees were asked to
report indicators that represent the benefit of the re-
accreditation (see Additional file 1). However, it ap-
peared that the connection between a benefit and the
re-accreditation was difficult to evaluate, i.e., all inter-
viewees reported great difficulties in saying whether a
benefit could be directly associated to the re-
accreditation and its activities. To evaluate whether
there is a link between an identified benefit and the
re-accreditation, the accountability criteria by Chassin
et al. [19] can be used, which are i) research-robust
evidence, ii) accuracy, iii) proximity, and iv) no ad-
verse effect. Mumford et al. [4] added specificity as a
fifth criterion to determine if the effects of accredit-
ation can be isolated from other safety and quality
measures. Despite the existence of such criteria,
Mumford et al. [14] demonstrated the complexity of
the identification of suitable indicators in their study,
which we also experienced here (see Additional file 1
for how we incorporated the criteria in the interview
guideline). For this reason, we asked the project
leaders to estimate, based on their experience and
knowledge, whether benefits occurred due to the re-
accreditation. The same holds for the costs that had
to be estimated.
As opposed to Mumford et al. [4], this study used one
semi-structured interview guideline containing questions
on costs and benefits, instead of several assessment
tools. The questions in the semi-structured interview
guideline were developed based on the questions from
the assessment tools by Mumford et al. [4]. As a full
qualitative analysis of the interviews was beyond the
scope of this study, an approach as the one proposed by
Halcomb and Davidson [20] was used. Field notes were
taken in addition to audio recording. Key information
was filtered out including standard-specific costs and
working hours/days as well as information on indicators
and the description of benefits.
Step 3: Quantification of costs and benefits
The quantification of costs was relatively straightfor-
ward. Either costs were already expressed in monetary
units, or, in the case of working days, they were multi-
plied by a daily rate. The quantification of benefits on
the other hand was significantly more complex. Most
importantly, benefits of re-accreditation were typically
not directly appraisable in monetary units. If benefits
occur in non-monetary terms (due to non-market goods
or services), a monetary value may be estimated [21].
The most common approaches include revealed and
stated preference methods [21]. Due to the specific
questions on re-accreditation in the KSGR and the lim-
ited resources available, this was not feasible in the
present study. Instead, where quantification of the bene-
fits was not possible, their description was considered to
be the outcome. In addition, for two standards (QM and
CIRS) a new way to quantify the benefits was developed.
Together with the project leaders, a quantification grid
was set up (see Additional file 2). The identified benefits
from the interview were sent to the nine members of the
quality commission to let them validate and rate the
listed benefits. Given this approach, we could assign a
numerical value to these benefits, which we call the
Expert-Rated Benefit (ERB) score. While of course not
equivalent to the approaches mentioned above that
can yield monetary values of benefits, this method
helped us to quantify the benefits in a standardized way.
Results
Identification and quantification of costs
The costs were collected for the whole accreditation
project. Identified costs of the re-accreditation include
costs for preparation and undergoing of the accredit-
ation for all eight standards. Table 1 lists the costs in
the interviews and the estimation by the quality man-
ager or project leaders. Costs were separated by in-
ternal and external. External costs refer to expenses
and payments made specifically in connection with
the re-accreditation (e.g., accreditation fees). Internal
costs include the amount of working days that em-
ployees spent for re-accreditation projects. Concerning
monetization, external costs were already expressed in
monetary units (CHF). Working days were monetized by
multiplying each day by CHF 800 (according to the hospi-
tal’s budget guideline).
The identified costs amount to CHF 873'319 in total.
Actual costs may slightly deviate from that because some
costs had to be estimated. When differentiating between
external and internal costs, external costs amount to
CHF 154'151 whereas internal costs amount to CHF
719'168. The amount of total costs shows in fact a sub-
stantial investment. However, it is important to differen-
tiate between internal and external costs. We can see
that internal costs represent approximately 82 % of the
total re-accreditation costs. Relative to the total amount
of hospital expenses in 2013 (CHF 298'866'000), this
amounts to only about 0.1 % annualized over three
years. Other studies found slightly higher but still similar
proportions of accreditation costs in total expenses of
0.3 % [22] and 1.7 % [12].
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Considering the standards “QM” and “surgery” the
costs in these standards appear to be higher compared
to the other standards. The reason for this can mainly
be found in personal intensive projects being carried out
in these standards. For example, the standard “surgery”
was involved in a nationwide project called “safe sur-
gery”. This did require a lot of additional working hours.
Identification and quantification of benefits
The identification of quality indicators would have been
a key requirement for quantifying the benefits of re-
accreditation. The project leaders were not able to re-
port suitable indicators that could be used to quantify
the benefits. This was because (numeric) indicators and/
or reliable data were missing. The project leaders were
able to name topics, projects and services that improved
in accordance with the re-accreditation. Consequently, it
was only possible to report the benefits in a descriptive
way rather than to quantify the data, with the exception
of QM and CIRS, where we could quantify the benefits
using our new validation tool. In the following, we will
describe the results regarding what the project leaders
considered to be the benefits of the re-accreditation.
When we first look at the nutrition standard, it reveals
a controversial picture. According to the project leader,
several benefits with additional profits of about CHF
1.5 Mio. have recently arisen due to different projects.
These profits mainly arose due to the coding of malnu-
trition as a side diagnosis in the national reimbursement
system. Some of the benefits of the nutrition standard
were also possibly the result of projects realized in line
with the first accreditation in 2011. Since this study fo-
cuses on the present re-accreditation cycle, and a direct
link to the re-accreditation could not be established for
these benefits and profits, they are not considered for a
more detailed analysis here.
Next, we examine the benefits of the surgery standard.
Table 2 lists the identified benefits from this standard. It
would have been feasible to collect data on specific indi-
cators (e.g., the number of hits on the surgery manual, a
survey on employee’s satisfaction with projects, or the
implementation of the surgery checklist). However, al-
most no data is available from prior to the accreditation
and hence no before/after comparison is possible. None-
theless, the described benefits represent important im-
provements that are valuable to the department and the
hospital in general. For example, a better reporting of
Table 2 Identified benefits in the Q-Standard surgery
Benefit Description
Better reporting on complications This benefit indicates a better capture of complications. This means increased quality, as experts
prefer to know about the occurrence of complications as much as possible.
Increase of pre surgery briefings of patients The rate of missing medical briefing protocols decreased from 6 to 0.5 % in the re-accreditation
cycle.
Actuality of the fact sheets and guidelines in
the surgery manual
Fact sheets and guidelines within the surgery manual are no longer outdated. Most fact sheets
are not older than three years. Consequently, employees use the manual more often.
Improvement of the meetings of the
complication board
Meetings of the complications board “complications conference” have improved qualitatively.
As a result, discussions during the meetings not only include statistical data but also case reviews.
Better overview on data collection Prior to the re-accreditation, each sub-division separately collected their own data. It was difficult
to overview what each sub-division did in case of data collection. As a consequence of the
re-accreditation, an overview on data collection exists which facilitates the search for data.
Table 1 Total identified costs regarding the sanaCERT re-accreditation (in CHFa)
Standard Internal costs External costs Subtotal
QM including sanaCERT suisse costs 171'803.81 86'500.30 258'304.11
Survey of patients’ satisfaction 12'400.00 5'840.00 18'240.00
Surgery 252'000.00 15'586.25 267'586.25
CIRS 29'523.81 45'904.60 75'428.41
Employees and the hospital 51'120.00 0.00 51'120.00
Diagnosis, treatment and care at the emergency station 16'000.00 0.00 16'000.00
Nutrition 9'520.00 0.00 9'520.00
Safe medication 176'800.00 320.00 177'120.00
Total costs identified 719'167.62 154'151.15 873'318.77
In percentage 82 % 18 % 100 %
a CHF = Swiss francs
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data on complications gives the experts the possibility to
learn more about the underlying issues. Concerning the
surgery manual, most of its documents and guidelines
are not older than three years anymore. This indicates
that the manual is up to date and used more frequently.
Juul et al. [23] come to a similar finding, namely that the
accreditation significantly increases both the quality and
availability of clinical guidelines.
With regard to the standards QM and CIRS, eight dif-
ferent benefits were identified in the interviews. Table 3
lists these benefits in the second column and also shows
the outcome of the benefit rating activity by the mem-
bers of the quality commission. Each expert rated every
of the eight benefits according to two dimensions: First,
the estimation of benefits on a scale form 0–3 (where 0
means no benefit, and 3 means enormous benefit), and
secondly, the penetration in the hospital on a scale from
1–4 (where 1 means penetration in one division, and 4
means penetration througout the hospital). The results
from the nine individual estimations by the experts for
the two categories were averaged, resulting in the esti-
mated benefits reported in Table 3, column 3, and the
expected penetration reported in column 4. In a next
step, these two numbers were multiplied (estimated
benefit times expected penetration), which yields the
ERB score for each benefit (column 5).
The ERB score makes it possible to quantify and to
compare the relative importance of the different benefits.
According to our validation tool, the benefits “complaint
management” and “quality-/safety culture” were rated
the highest (7.5 and 10.3 points, respectively, out of 12
points at maximum). This indicates that those two bene-
fits were evaluated as most important regarding the
standards QM and CIRS by the experts. The order of
the other benefits is: [3] fulfillment of the hospital vision,
[4] improved image upon stakeholders (patients, sup-
pliers etc.), [5] improved image in policy, [6] quality
dashboard, [7] preparation of centralized quality docu-
ments, and [8] avoidance of liability cases.
The average ERB score over the eight identified bene-
fits gives a value of 5.24. Assuming a conservative uni-
form distribution for the estimated benefit ratings and
the expected penetration ratings with a correlation of
0.77 (which is the correlation found in the actual re-
sponses) we obtain a theoretical mean ERB score of 4.62,
and thus the re-accreditation achieves an above-average
rating by the experts in the selected benefits.
Finally, it was possible to identify a general benefit of
the re-accreditation, namely a cultural benefit. This
means that the presence of the re-accreditation awards
the hospital a good reputation, at least temporarily. As
hospital accreditation seems to be a general trend and
something that the public possibly asks for, being accre-
dited may itself be seen as a benefit. In this regard,
Grepperud [2] described a possible shift in demand in
favor of accredited hospitals if individuals value accre-
dited hospitals more than non-accredited ones. This
may result in a higher market share of accredited hospi-
tals, which Grepperud [2] described as benefit. Further-
more, feeling the pressure of being audited may
accelerate the process and implementation of some pro-
jects (e.g., the nutrition concept).
Discussion
The total identified costs of CHF 873'319 are a substan-
tial investment, which gives immediate reason to ques-
tion the decision to re-accredit the hospital. However,
the number becomes relativized since the major part of
the costs are internal amounting to CHF 719'168. For
some of these internal costs, it may be questioned
whether they exclusively arose because of the re-
accreditation. One might conjecture that at least some
of the working days and part of the expenses would have
arisen also in the absence of the re-accreditation. In
Table 3 Non-quantifiable benefit concerning the Q-Standards Quality Management and CIRS
Benefit Nr. Reprocessed topics with benefits or assumed benefit
of the sanaCERT re-accreditation
Estimated benefita Expected penetrationb ERB score
1 Implementation of the hospital-wide complaint management 2.11 3.56 7.51
2 Preparation of centralized quality documents 1.22 2.89 3.53
3 Quality Dashboard 1.44 2.67 3.85
4 Development or promotion of a quality - or safety culture 3.00 3.44 10.33
5 Avoidance of liability cases 1.00 1.89 1.89
6 Improved image upon stakeholders (patients, suppliers etc.) 1.56 3.11 4.84
7 Improved image in policy 1.67 2.78 4.63
8 Fulfillment of the KSGR vision 1.78 3.00 5.33
Average ERB score 5.24
Note: a = Benefits are rated on 0–3 scale with 0 = no benefit and 3 = very high benefit; b = Penetration is rated on a 1–4 scale with 1 = one division, 2 = one
department, 3 = multiple departments, 4 = hospital-wide. Estimations are based on nine expert ratings. The ERB score is calculated as product of estimated benefit
and penetration. The average ERB score is calculated as average over the eight benefits
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addition, putting the costs in relation to the hospital’s
total expenses, they account for only about 0.1 %, which
is even lower than the numbers found in related studies.
Hospital experts estimated a variety benefits in the
studied standards of the KSGR, as a result of the re-
accreditation. These include overall benefits, such as a
cultural benefit, and more specific benefits like the im-
proved capturing of complications in the surgery depart-
ment. The quantified benefits of the standards QM and
CIRS were quantified using a newly developed validation
tool that assigns numerical values to the benefits. This
can be seen as a step towards the quantification of de-
scriptive benefits. According to this tool, the complaint
management and quality or safety culture appear to be
the most valued benefits. The average ERB score points
to an overall beneficial effect of the re-accreditation and
reinforces the use of accreditation as a quality assurance
instrument.
The present study provides two major findings. First,
it identifies the total costs and the benefits of the studied
areas that arise from the re-accreditation of an acute
care hospital in Switzerland. Secondly, it confirms the
complexity of hospital accreditation as a subject matter
and especially the problems involved in quantifying the
benefits for further economic evaluation. This second
aspect in particular may be the reason for the lack of
relevant literature in the field of economic evaluation of
hospital accreditation.
Due to the difficulty of quantifying and monetizing
the benefits it was impossible to carry out a formal
CBA, as designated by the SIQNS framework. Consid-
ering the type of analysis, our study probably comes
closer to a CUA (in terms of economic evaluation
methodology) due to the indirect valuation of the
benefits of the standards QM and CIRS. Our results
highlight that an economic evaluation of hospital ac-
creditation is not impossible, though hard to carry
out. Once proper data is available that allows for a
quantification and monetization of benefits, it seems
reasonable to conduct a formal CBA. A prospective
view may help in the future to assure that quantifi-
able data is available. Maybe complementary to trad-
itional approaches of valuing program benefits, the
benefit identification procedure suggested here can be
used to assess the benefits in absence of valid indica-
tors and data. Thus, future studies may take place in
a setting that allows for a more comprehensive view
on assessing the benefits of (re-) accreditation. Finally,
when looking at the decision to accredit, other as-
pects may be considered as well. To this end, Grepperud
[2] suggested to incorporate how decisions depend on
competition, the regulatory environment and the pres-
ence of alternative methods for evaluating hospital
performance.
Our study also has several limitations. It needs to be
acknowledged that both the benefit identification and
quantification were mainly based on subjective estimates
and thus are prone to bias. In addition, the project
leaders faced an extremely difficult task by saying
whether the respective benefits were clearly related to
the re-accreditation, even though they were given some
assistance with the accountability criteria in the inter-
view guideline. Moreover, not all of the accountability
criteria could be applied and in the end, the decision
was mainly based on subjective estimates of the experts.
Consequently, it was not possible to carry out a detailed
analysis for the identification of possible indicators as
proposed by Mumford et al. [4]. Only four out of eight
standards were included in the study, which likely does
not represent the full impact of the re-accreditation. By
considering all eight standards, the total benefit of the
re-accreditation may be higher. Concerning the costs,
some of the internal costs needed to be estimated, which
in fact may not represent the actual costs spent for the
re-accreditation. However, in most cases, the costs and
amount of working days are well documented and esti-
mation should be sufficiently precise.
Conclusion
This study assessed the costs and benefits of re-
accreditation of an acute-care hospital in Switzerland.
Due to the lack of suitable indicators and data, a for-
mal CBA could not be carried out. However, we sug-
gest a novel validation tool that helps to quantify the
descriptive benefits and that sets a basis for further
research. The interpretation of the cost side of re-
accreditation must consider the difference between in-
ternal and external costs to get a precise picture as
some costs might have arisen even in the absence of
the re-accreditation. The quantification of benefits is
a difficult task. Nonetheless, this study provides a
new approach to quantify the benefits in the given
setting. After all, the study confirms the complexity
and difficulty of economic evaluation of hospital ac-
creditation. For this reason, a prospective and more
comprehensive setting seems to be more feasible for
future studies.
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